10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Genomics delivered a solid Q3 quarter with revenue reaching $154M, growing 17% YoY. The company has ...
On Wednesday, 10x Genomics Inc (NASDAQ:TXG) reported a fourth-quarter EPS loss of $(0.40), missing the consensus estimate of $(0.30). The single-cell and spatial biology company reported quarterly ...
SAN FRANCISCO BAY AREA, Calif., April 22, 2026 /PRNewswire/ -- 10x Science, which builds frontier AI for molecular-level protein characterization across the life sciences, today announced the closing ...
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, today announced the ...
Hosted on MSN
Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & services industry, including 10x Genomics (NASDAQ:TXG) and its peers. The life ...
Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making advanced analysis more accessible to the broader ...
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers. The life sciences tools and services ...
Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 5.4% in the afternoon session after a key industry peer, Thermo ...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and 10x Genomics, Inc., a leader in single cell and spatial biology, today announced a new partnership to expand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results